Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy

Source: Nasdaq GlobeNewswire / 23 May 2018 05:30:45   America/Los_Angeles